Depression: 2025 Statistics

Back to Top

Depressive disorder, commonly known as depression, is a serious and prevalent mental health condition characterised by persistent sadness and a loss of interest or pleasure in previously rewarding or enjoyable activities. It can significantly impair daily functioning and is a leading cause of disability worldwide.

Globally, an estimated 280 million people live with depression. This widespread issue affects individuals across all ages and demographics, and its impact on well-being and public health is profound, contributing to hundreds of thousands of deaths by suicide each year.

• Overall Prevalence and General Numbers
• Breakdown by Key Demographics
• Co-occurrence and Related Conditions
• The Most Serious Consequences
• The Positive Outlook and Solutions
• Conclusion
• Sources

Overall Prevalence and General Numbers

• Global Prevalence: An estimated 3.8% of the world's population experiences depression.
• Impact of COVID-19: The pandemic triggered a massive spike in mental health issues, causing an additional 76.2 million cases of major depressive disorders globally in 2020 alone.
• Prevalence in the US: In the United States, an estimated 8.3% of all adults (21 million people) had at least one major depressive episode in 2021.
• A Leading Cause of Disability: Depression is the second-leading cause of disability worldwide and a major contributor to the overall global burden of disease.

Back to Top

---

Breakdown by Key Demographics

• By Age Group (US Data):
  • Prevalence is highest among young adults, with 18.6% of those aged 18-25 experiencing a major depressive episode.
  • Adolescents (ages 12-17) also face high rates, with 20.1% having experienced a major depressive episode.
  • In contrast, the global prevalence for adults over 60 is 5.7%.
• By Gender:
  • Depression is approximately 50% more common among women than men globally.
  • In the US, this disparity is clear: 10.3% of adult females experienced a major depressive episode compared to 6.2% of adult males.
  • The gap is even wider among adolescents, with a prevalence of 29.2% for females versus 11.5% for males.
• By Race/Ethnicity (US Data):
  • The prevalence of major depressive episodes was highest among adults who reported belonging to two or more races, at 13.9%.

Back to Top

---

Co-occurrence and Related Conditions

• Co-morbidity: Depression is closely linked with physical health. It can increase the risk of conditions like cardiovascular disease and diabetes, and it often co-occurs with other mental health issues, such as anxiety and substance use disorders.
• Key Risk Factors: Adverse life events, including unemployment, bereavement, and psychological trauma, are significant risk factors for developing depression.

Back to Top

---

The Most Serious Consequences

Untreated depression can lead to severe functional impairment, social and economic losses, and, in the most tragic cases, death by suicide.

• Functional Impairment: In the US, 69.2% of adults who experienced a major depressive episode reported severe impairment in their daily functioning.
• Suicide and Mortality:
  • Globally, more than 720,000 people die due to suicide every year.
  • Suicide is the third leading cause of death among 15 to 29-year-olds.
  • In the US alone, there were 49,476 deaths by suicide in 2022.
• Healthcare System Impact (US): In 2019, there were 15.0 million physician office visits with depressive disorders as the primary diagnosis.

Back to Top

---

The Positive Outlook and Solutions

While the statistics are sobering, effective treatments for depression are well-established. The primary challenge lies in bridging the vast global treatment gap.

• Effective Treatments Exist: Psychological treatments like Cognitive Behavioural Therapy (CBT) and antidepressant medications are proven to be effective for moderate to severe depression.
• The Global Treatment Gap: A significant barrier to recovery is access to care. In low- and middle-income countries, more than 75% of people with mental disorders receive no treatment at all.
• Treatment Gaps in High-Income Countries (US):
  • Among US adults with a major depressive episode, 61.0% received treatment.
  • The gap is much larger for youth: only 40.6% of adolescents with a major depressive episode received treatment.
• Global Action: The World Health Organisation’s Mental Health Action Plan and mhGAP Programme are key initiatives aimed at scaling up care for mental health conditions worldwide.

Back to Top

---

Conclusion

Depression is a common, serious, and disabling illness that affects hundreds of millions globally. While effective treatments are available, a massive treatment gap means most people, especially in lower-income countries and among youth, do not receive the care they need. Addressing this gap through increased investment, integrated care, and reduced stigma is one of the most pressing public health challenges of our time.

Back to Top

---

Sources

• World Health Organisation (WHO). (2023). Depression.
• World Health Organisation (WHO). (2025). Suicide.
• National Institute of Mental Health (NIMH). (2021 data). Major Depression.
• Centers for Disease Control and Prevention (CDC). (Data from 2019-2023). FastStats - Depression.
• Institute for Health Metrics and Evaluation (IHME). (2021). New Global Burden of Disease analyses show depression and anxiety disorders increased dramatically during the COVID-19 pandemic.
• Substance Abuse and Mental Health Services Administration (SAMHSA). (2021 data). National Survey on Drug Use and Health (NSDUH).

Back to Top